D
Donald R. McLachlan
Researcher at University of Toronto
Publications - 52
Citations - 4283
Donald R. McLachlan is an academic researcher from University of Toronto. The author has contributed to research in topics: Alzheimer's disease & Senile plaques. The author has an hindex of 28, co-authored 52 publications receiving 4144 citations. Previous affiliations of Donald R. McLachlan include Toronto General Hospital.
Papers
More filters
Journal ArticleDOI
Intramuscular desferrioxamine in patients with Alzheimer's disease.
Donald R. McLachlan,Theo P.A. Kruck,W. Kalow,David F. Andrews,A.J. Dalton,M.Y. Bell,W.L. Smith +6 more
TL;DR: It is concluded that sustained administration of desferrioxamine may slow the clinical progression of the dementia associated with AD.
Journal Article
Intramuscular desferrioxamine in patients with Alzheimer's disease
TL;DR: In this paper, a single-blind study was conducted to investigate whether the progression of dementia could be slowed by the trivalent ion chelator, desferrioxamine.
Journal ArticleDOI
Retrieval without Recollection: An Experimental Analysis of Source Amnesia
TL;DR: In this article, a paradigm was developed in which either of two experimenters read subjects statements about fictional characteristics of well-known and unknown people; retention of items and sources was tested after varying delays.
Journal ArticleDOI
Priming of semantic autobiographical knowledge: a case study of retrograde amnesia
TL;DR: A 36-year-old man who suffers dense retrograde and anterograde amnesia as a result of closed-head injury that caused extensive damage to his left frontal-parietal and right parieto-occipital lobes is described.
Journal ArticleDOI
Reduction of vitamin D hormone receptor mRNA levels in Alzheimer as compared to Huntington hippocampus: correlation with calbindin-28k mRNA levels
M. K. Sutherland,Martin J. Somerville,Larry K.K. Yoong,Catherine Bergeron,Catherine Bergeron,Mark R. Haussler,Donald R. McLachlan +6 more
TL;DR: Results show that in Alzheimer hippocampal CA1 cells, VDR mRNA pool size is downregulated and that this downregulation may play a role in the reduction of calbindin-28k expression.